Alcon AG

ALC.US
Healthcare · Medical Instruments & Supplies
69.11
+1.83 (+2.72%)
USD · NYSE

Company Information

Company Name
Alcon AG
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NYSE
ISIN: CH0432492467
CIK: 0001167379
Currency: USD
Full Time Employees: 25,000
Phone: 41 589 112 110
Fiscal Year End: December
IPO Date: Apr 09, 2019
Description:

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Address:

Chemin de Blandonnet 8, Geneva, Switzerland, 1214

People

Directors & Officers

Name Title Year Born
Mr. David J. Endicott CEO & Director 1965
Mr. Timothy C. Stonesifer Senior VP & CFO 1967
Mr. Ian Bell Senior VP & COO 1971
Margaret Buckley Chief Accounting Officer NA
Dr. Franck Leveiller Ph.D. SVP of Global Research & Development and Chief Scientific Officer NA
Mr. Muru Murugappan Senior VP and Chief Information & Transformation Officer NA
Mr. Daniel Cravens Vice President of Investor Relations NA
Mr. Royce R. Bedward J.D. Senior VP, General Counsel & Corporate Secretary 1966
Ms. Kimberly Martin Senior VP and Chief HR & Corporate Communications 1975
Mr. Leon Sergio Duplan Fraustro Senior VP & President of Americas 1968

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 21.46M Dec 31, 2025 4.40% $0.02 1.27%
Bank of New York Mellon Corp 15.67M Mar 31, 2026 3.21% $0.22 18.79%
Vanguard Capital Management, LLC 14.87M Mar 31, 2026 3.05% $0.03 0.00%
FMR Inc 12.43M Mar 31, 2026 2.55% $0.05 15.51%
NORGES BANK 12.05M Dec 31, 2025 2.47% $0.10 6.23%
Aristotle Capital Management LLC 9.72M Mar 31, 2026 1.99% $1.53 -4.21%
Ako Capital Llp 9.32M Mar 31, 2026 1.91% $13.62 21.31%
Zurcher Kantonalbank 8.02M Mar 31, 2026 1.65% $1.29 3.65%
UBS Group AG 5.93M Mar 31, 2026 1.22% $0.07 -8.23%
The Goldman Sachs Group Inc 5.82M Mar 31, 2026 1.19% $0.05 22.16%
Amundi 5.71M Mar 31, 2026 1.17% $0.12 8.09%
Select Equity Group LP 5.68M Mar 31, 2026 1.16% $2.14 -8.72%
Vontobel Holding Ltd. 5.46M Mar 31, 2026 1.12% $1.39 24.21%
Deutsche Bank AG 4.98M Mar 31, 2026 1.02% $0.12 -4.66%
Pictet Asset Manangement SA 4.98M Mar 31, 2026 1.02% $0.39 0.23%
Vanguard Fiduciary Trust Co 4.35M Mar 31, 2026 0.89% $0.08 0.00%
Franklin Resources Inc 4.29M Mar 31, 2026 0.88% $0.08 -15.15%
Royal Bank of Canada 4.16M Mar 31, 2026 0.85% $0.06 0.52%
Allspring Global Investments Holdings, LLC 4.13M Mar 31, 2026 0.85% $0.52 44.69%
Legal & General Group PLC 3.95M Mar 31, 2026 0.81% $0.07 1.37%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 UBS: Global Equity 8.14M 1.67% ▲ 0.00% Mar 31, 2026
2 Vanguard Total Intl Stock Index Inv 7.16M 1.47% ▼ 1.46% Jun 30, 2026
3 Vanguard Developed Markets Index Admiral 4.76M 0.98% ▼ 1.53% Jun 30, 2026
4 iShares Core MSCI EAFE ETF 3.68M 0.75% ▲ 0.00% Jun 30, 2026
5 Vanguard Instl Ttl Intl Stk Mkt Idx TrII 3.61M 0.74% ▼ 1.39% Jun 30, 2026
6 Allspring Special Mid Cap Value Inst 3.28M 0.67% ▲ 0.00% Jun 30, 2026
7 Allspring Special US Mid Cap Value Eq 3.28M 0.67% ▲ 0.82% Jun 30, 2026
8 Allspring Mid Value SMA 3.28M 0.67% ▲ 906,985.64% Jun 30, 2026
9 UBS(CH)IF Equities CH All NSL I-B-acc 3.13M 0.64% ▲ 0.81% Jun 30, 2026
10 Vanguard Windsor II Inv 2.92M 0.60% ▲ 0.00% Mar 31, 2026

Financial Highlights

Market Cap: $33.70B
EBITDA: $2.31B
P/E Ratio: $41.38
PEG Ratio: $1.52
Book Value: $45.38
Dividend/Share: $0.35
Dividend Yield: 0.53%
Earnings/Share: $1.67
Profit Margin: 7.70%
Operating Margin: 12.20%
ROA (TTM): 2.55%
ROE (TTM): 3.71%
Revenue (TTM): $10.63B
Revenue/Share (TTM): $21.65
Earnings Growth (YOY): -44.60%
Revenue Growth (YOY): 9.40%

Valuation Metrics

Enterprise Value: $37.22B
Trailing P/E: 41.38
Forward P/E: 19.61

Shares Statistics

Shares Outstanding: 487.70M
Shares Float: 486.14M
% Insiders: 17.50%
% Institutions: 6,622.50%
Short % Float: 1.52%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$10.40B
Cost of Goods Sold
adjust
$-4.66B
Gross Profit
subtotal
$5.75B
SG&A
adjust
$-3.45B
R&D
adjust
$-990.00M
Operating Income
subtotal
$1.36B
Other / Non-Operating Items
adjust
$-380.00M
Net Income
subtotal
$980.00M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ALC.US!